J&J vaccine booster protects against severe omicron illness hospitalization, company says

A real-life study from South Africa said that the J&J vaccine was 85% effective against hospitalization, even after the omicron variant appeared.“When a booster shot was administered six to nine months after a primary single dose, vaccine effectiveness increased over time from 63 percent at 0-13 days, to 84 percent at 14-27 days and 85 percent at 1-2 months post-boost,” J&J said in a statement.reported.

In cases where the J&J shot was used as a booster in patients who first had Pfizer/BioNTech’s vaccine, they had a 41-fold increase in antibodies and a five-fold increase in T-cells,The Pfizer and J&J results were compared to results in people who got only Pfizer as the three-shot series,After four weeks, the Pfizer and J&J regimen resulted in a 17-fold increase in antibodies and a 1.4-fold increase in T-cells.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Studies indicate J&J Covid-19 vaccine booster protects people against severe illness from Omicron variantTwo reports released Thursday show that people who get booster doses of Johnson & Johnson's Janssen vaccine are well protected against severe disease and hospitalization from the Omicron variant of coronavirus, the company said. Showww No thanks There is no severe illness from Omicron,at least not where I am..
Source: CNN - 🏆 4. / 95 Read more »